Dr. Aliasger Salem is the Associate Vice President for Research at the University of Iowa. His expertise lies in drug delivery, regenerative medicine, and cancer therapies, with a focus on nanotechnology and biomaterials. A graduate of the University of Nottingham, he has co-founded two spin-off companies, TEAM Technologies and Kassara.
Dr. Salem is deeply committed to the scientific community, serving as president of the American Association of Pharmaceutical Scientists (AAPS) and actively fostering international research partnerships. He frequently highlights the achievements of his students and colleagues, demonstrating a passion for mentorship and collaboration within pharmaceutical sciences.
He holds over 20 patents for his work and was named a fellow of the National Academy of Inventors.
Read the full overview →They prefer to do thorough analysis of any situation. They generally do not appreciate an overfriendly approach and prefer to stay to-the-point. While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.